AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 64 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $18,000 | +125.0% | 34,478 | +125.4% | 0.00% | – |
| Q2 2022 | $8,000 | -97.5% | 15,299 | -62.9% | 0.00% | -100.0% |
| Q4 2019 | $315,000 | -0.6% | 41,193 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $317,000 | -49.5% | 41,193 | -55.1% | 0.00% | -50.0% |
| Q2 2019 | $628,000 | -13.4% | 91,709 | +1.8% | 0.00% | -33.3% |
| Q1 2019 | $725,000 | -22.2% | 90,109 | -27.6% | 0.00% | -25.0% |
| Q4 2018 | $932,000 | -67.5% | 124,408 | -58.5% | 0.00% | -60.0% |
| Q3 2018 | $2,866,000 | -16.8% | 299,436 | -8.0% | 0.01% | -28.6% |
| Q2 2018 | $3,445,000 | – | 325,611 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 340,679 | $3,604,000 | 1.39% |
| Nantahala Capital Management | 2,213,052 | $23,414,000 | 0.95% |
| SCP Investment, LP | 156,137 | $1,652,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 509,118 | $5,386,000 | 0.74% |
| DELTEC ASSET MANAGEMENT LLC | 151,781 | $1,606,000 | 0.32% |
| Rock Springs Capital Management LP | 650,000 | $6,877,000 | 0.26% |
| Orbimed Advisors | 1,865,524 | $19,737,000 | 0.24% |
| Baker Brothers Advisors | 1,387,872 | $14,684,000 | 0.11% |
| EAM Investors, LLC | 56,726 | $600,000 | 0.10% |
| Stanley-Laman Group, Ltd. | 35,036 | $371,000 | 0.08% |